GlassScriptPhysician profile
Mason Scott Holtel
NPI 1518429372
$5,308.66
in general payments reported to CMS, 2019-2025
15 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $568 · 2023: $627 · 2024: $2,969 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,529 · Travel and Lodging: $2,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,528.67 |
| Travel and Lodging | $2,212.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,009.86 | 2022-2025 | Ams 700, Advance Xp, Tactra |
| Medtronic, INC. | $968.67 | 2022-2025 | Interstim |
| Cook Incorporated | $825.35 | 2024 | S~Curve |
| Cook Medical LLC | $310.66 | 2024 | S~Curve, Resonance, Cook |
| Procept Biorobotics Corporation | $225.47 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $136.49 | 2025 | |
| Myriad Genetic Laboratories, INC. | $135.55 | 2023-2024 | Prolaris |
| Sumitomo Pharma America, INC. | $133.75 | 2023-2025 | Gemtesa |
| Dendreon Pharmaceuticals LLC | $133.69 | 2025 | Provenge |
| Pfizer INC. | $124.99 | 2023 | |
| Urogen Pharma, INC. | $114.85 | 2023-2025 | Jelmyto |
| Karl Storz Endoscopy-America | $81.22 | 2023 | Tele Pack |
| Progenics Pharmaceuticals, INC. | $52.85 | 2024 | |
| Axonics, INC. | $45.36 | 2024 | Axonics |
| Laborie Medical Technologies Corp. | $9.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mason Holtel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.